Evaluating Innate Immune Responses in Dendritic Cells During HIV Infection

评估 HIV 感染期间树突状细胞的先天免疫反应

基本信息

项目摘要

Infection with human immunodeficiency virus (HIV) leads to the devastating loss of CD4+ T cells and progression to acquired immunodeficiency syndrome (AIDS). As of 2010, roughly 33.3 million people were living with HIV/AIDS worldwide (44, 49), and despite the advent of anti-retroviral therapy, HIV infection is still considered a global pandemic. An effective vaccine or cure for HIV infection remains elusive in part because basic principles of how HIV is sensed by the immune system are not completely clear. Clues for how HIV infection could be curtailed can be found in a population of HIV-infected individuals termed 'elite controllers', that are able to maintain plasma levels of virions to less than 50 copis per ml and do not progress to AIDS. These rare individuals exhibit a remarkable ability to 'control' viral infection and compared to other infected individuals they display a qualitatively different CD8+ T cell response, which may be critical for host control of viremia. With this projec we seek to elucidate pathways of HIV-mediated activation of immune responses in dendritic cells (DCs), professional antigen presenting cells that link innate detection of microorganisms to cellular and adaptive immune responses. Our laboratory has recently shown the existence of an interferon regulatory factor 3 (IRF3)-dependent innate response to HIV in DCs (24), but this response is cryptic since HIV does not typically infect DCs. For this project we will study pathways of innate immune signaling in DCs and evaluate how cellular components can 'sense' viral infection. To this end we propose the following aims: 1) explore how HIV-1 influences an innate response in DCs through the IRF3 pathway; and 2) examine whether innate activation and cytokine production in DCs is fundamentally different in HIV-infected elite controllers. Ultimately, we hope to recapitulate what processes may be at play in elite controllers and improve our understanding of HIV pathogenesis.
人类免疫缺陷病毒(HIV)的感染导致CD4+ T细胞的毁灭性丧失,并发展为获得的免疫缺陷综合征(AIDS)。截至2010年,全球大约有3330万人患有艾滋病毒/艾滋病(44,49),尽管抗逆转录病毒疗法出现了,但艾滋病毒感染仍被认为是全球性大流行。一种有效的艾滋病毒感染疫苗或治疗仍然难以捉摸,部分原因是免疫系统如何感知HIV的基本原理并不完全清楚。在称为“精英控制者”的艾滋病毒感染者中,可以发现如何减少HIV感染的线索,这些人能够将血浆水平的病毒粒子水平维持在每毫升不足50 copis且不发展为艾滋病。这些罕见的个体具有“控制”病毒感染的显着能力,并将其与其他受感染的个体进行了比较,它们在质量上不同的CD8+ T细胞反应表现出了不同的能力,这对于病毒血症的宿主控制可能至关重要。使用此ProJEC,我们试图阐明树突状细胞中免疫反应激活的途径(DCS),专业抗原呈现细胞,这些细胞将微生物的先天检测与细胞和适应性免疫反应联系起来。我们的实验室最近显示了干扰素调节因子3(IRF3)对DC中对HIV的先天反应的存在(24),但是这种反应是隐秘的,因为HIV通常不感染DCS。 For this project we will study pathways of innate immune signaling in DCs and evaluate how cellular components can 'sense' viral infection. To this end we propose the following aims: 1) explore how HIV-1 influences an innate response in DCs through the IRF3 pathway; and 2) examine whether innate activation and cytokine production in DCs is fundamentally different in HIV-infected elite controllers. Ultimately, we hope to recapitulate what processes may be at play in elite controllers and improve our understanding of HIV pathogenesis.

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jarrod Sean Johnson其他文献

Jarrod Sean Johnson的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jarrod Sean Johnson', 18)}}的其他基金

Regulation and Manipulation of Innate Immunity During HIV Infection
HIV 感染期间先天免疫的调节和操纵
  • 批准号:
    10874020
  • 财政年份:
    2023
  • 资助金额:
    $ 0.31万
  • 项目类别:
Evaluating Innate Immune Responses in Dendritic Cells During HIV Infection
评估 HIV 感染期间树突状细胞的先天免疫反应
  • 批准号:
    8330070
  • 财政年份:
    2012
  • 资助金额:
    $ 0.31万
  • 项目类别:
Enhancing Gene Therapy by Designing Chimeric AAV Virions
通过设计嵌合 AAV 病毒颗粒增强基因治疗
  • 批准号:
    7276307
  • 财政年份:
    2007
  • 资助金额:
    $ 0.31万
  • 项目类别:
Enhancing Gene Therapy by Designing Chimeric AAV Virions
通过设计嵌合 AAV 病毒颗粒增强基因治疗
  • 批准号:
    7467298
  • 财政年份:
    2007
  • 资助金额:
    $ 0.31万
  • 项目类别:
Enhancing Gene Therapy by Designing Chimeric AAV Virions
通过设计嵌合 AAV 病毒颗粒增强基因治疗
  • 批准号:
    7664308
  • 财政年份:
    2007
  • 资助金额:
    $ 0.31万
  • 项目类别:

相似国自然基金

海洋缺氧对持久性有机污染物入海后降解行为的影响
  • 批准号:
    42377396
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
氮磷的可获得性对拟柱孢藻水华毒性的影响和调控机制
  • 批准号:
    32371616
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目
还原条件下铜基催化剂表面供-受电子作用表征及其对CO2电催化反应的影响
  • 批准号:
    22379027
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目
CCT2分泌与内吞的机制及其对毒性蛋白聚集体传递的影响
  • 批准号:
    32300624
  • 批准年份:
    2023
  • 资助金额:
    10 万元
  • 项目类别:
    青年科学基金项目
在轨扰动影响下空间燃料电池系统的流动沸腾传质机理与抗扰控制研究
  • 批准号:
    52377215
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目

相似海外基金

Characterization of JT-4-173, a Potent Antiviral that Inhibits HIV-1 by a Novel Mechanism of Action
JT-4-173 的表征,一种通过新颖作用机制抑制 HIV-1 的强效抗病毒药物
  • 批准号:
    10762518
  • 财政年份:
    2023
  • 资助金额:
    $ 0.31万
  • 项目类别:
Influence of fetal antiretroviral exposure on gut microbiota, systemic inflammation and neurodevelopment in infants exposed to HIV
胎儿抗逆转录病毒暴露对暴露于 HIV 的婴儿的肠道微生物群、全身炎症和神经发育的影响
  • 批准号:
    10617395
  • 财政年份:
    2023
  • 资助金额:
    $ 0.31万
  • 项目类别:
Changes in Enteric Microbiota and Inflammation with HIV PrEP
HIV PrEP 引起的肠道微生物群变化和炎症
  • 批准号:
    10700595
  • 财政年份:
    2023
  • 资助金额:
    $ 0.31万
  • 项目类别:
Examining Social Determinants of Antiretroviral Adherence Trajectories among African American Adults with HIV
检查非洲裔美国成人艾滋病毒感染者抗逆转录病毒药物依从轨迹的社会决定因素
  • 批准号:
    10700611
  • 财政年份:
    2023
  • 资助金额:
    $ 0.31万
  • 项目类别:
HIV Tat-associated Sensory Neuropathy and the Contribution of Toll-like Receptor Pathway
HIV Tat 相关感觉神经病变和 Toll 样受体通路的贡献
  • 批准号:
    10838798
  • 财政年份:
    2023
  • 资助金额:
    $ 0.31万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了